JP2010037295A - Germicidal disinfectant solution and germicidal disinfectant - Google Patents
Germicidal disinfectant solution and germicidal disinfectant Download PDFInfo
- Publication number
- JP2010037295A JP2010037295A JP2008203929A JP2008203929A JP2010037295A JP 2010037295 A JP2010037295 A JP 2010037295A JP 2008203929 A JP2008203929 A JP 2008203929A JP 2008203929 A JP2008203929 A JP 2008203929A JP 2010037295 A JP2010037295 A JP 2010037295A
- Authority
- JP
- Japan
- Prior art keywords
- sterilizing
- disinfecting
- weight
- disinfectant
- base fabric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 26
- 230000002070 germicidal effect Effects 0.000 title abstract 9
- 239000004744 fabric Substances 0.000 claims abstract description 60
- 150000001413 amino acids Chemical class 0.000 claims abstract description 30
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 25
- 239000004475 Arginine Substances 0.000 claims abstract description 7
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 7
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims abstract description 7
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004472 Lysine Substances 0.000 claims abstract description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 7
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000003840 hydrochlorides Chemical class 0.000 claims abstract description 5
- 239000002657 fibrous material Substances 0.000 claims abstract description 3
- 230000000249 desinfective effect Effects 0.000 claims description 76
- 230000001954 sterilising effect Effects 0.000 claims description 75
- 239000007788 liquid Substances 0.000 claims description 26
- -1 biguanide compound Chemical class 0.000 claims description 25
- 239000007864 aqueous solution Substances 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 17
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 11
- 239000004359 castor oil Substances 0.000 claims description 11
- 235000019438 castor oil Nutrition 0.000 claims description 11
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 11
- 229920000297 Rayon Polymers 0.000 claims description 10
- 239000004745 nonwoven fabric Substances 0.000 claims description 10
- 239000002964 rayon Substances 0.000 claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 5
- 229940123208 Biguanide Drugs 0.000 claims description 3
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 3
- 239000003206 sterilizing agent Substances 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 10
- 230000003405 preventing effect Effects 0.000 abstract description 10
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 235000001014 amino acid Nutrition 0.000 description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 229960000686 benzalkonium chloride Drugs 0.000 description 10
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 10
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 8
- 229930064664 L-arginine Natural products 0.000 description 8
- 235000014852 L-arginine Nutrition 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
- 229910052782 aluminium Inorganic materials 0.000 description 7
- 239000005001 laminate film Substances 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 235000009697 arginine Nutrition 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 238000004061 bleaching Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229960004194 lidocaine Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229960001950 benzethonium chloride Drugs 0.000 description 3
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 2
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 2
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229960002206 bifonazole Drugs 0.000 description 2
- 229960004830 cetylpyridinium Drugs 0.000 description 2
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 2
- 229960003338 crotamiton Drugs 0.000 description 2
- 229960000520 diphenhydramine Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- NTCYWJCEOILKNG-ROLPUNSJSA-N [(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]-dimethylazanium;chloride Chemical compound Cl.CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 NTCYWJCEOILKNG-ROLPUNSJSA-N 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229960002798 cetrimide Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 229940073563 dl- methylephedrine hydrochloride Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229960005016 naphazoline Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Abstract
Description
本発明は、第四級アンモニウム塩またはビグアナイド系化合物などの正電荷を帯びた殺菌消毒成分を有する殺菌消毒液と、これを基布に含浸させてなる殺菌消毒剤とに関するものである。 The present invention relates to a sterilizing liquid having a positively charged sterilizing and disinfecting component such as a quaternary ammonium salt or a biguanide compound, and a sterilizing and disinfecting agent obtained by impregnating the sterilizing liquid with a base cloth.
塩化ベンザルコニウム、塩化ベンゼトニウムなどの第四級アンモニウム塩は、手指の殺菌消毒や患部の殺菌消毒液として汎用されている。これらの殺菌消毒液は脱脂綿、ガーゼ、不織布などの基布に適量を含浸させて使用されることが多い。 Quaternary ammonium salts such as benzalkonium chloride and benzethonium chloride are widely used as sterilization and disinfection solutions for fingers and affected areas. These sterilizing and disinfecting liquids are often used by impregnating appropriate amounts of base fabric such as absorbent cotton, gauze, and non-woven fabric.
しかし、このような使用方法では、これらの殺菌消毒成分が基布に吸着され、有効に殺菌消毒効果を発揮できない不都合があった。 However, such a method of use has the disadvantage that these sterilizing / disinfecting components are adsorbed on the base fabric and cannot effectively exhibit the sterilizing / disinfecting effect.
そこで、従来より、このような不都合を解消するために、ハロゲン化セチルトリメチルアンモニウムまたはハロゲン化セチルピリジニウムを添加する方法(特許文献1参照)や、アミノ酸型界面活性剤であるN−ヤシ油脂肪酸アシル−L−アルギニンエチル・DL−ピロリドンカルボン酸塩を添加する方法(特許文献2参照)が提案されている。
しかし、ハロゲン化セチルトリメチルアンモニウムまたはハロゲン化セチルピリジニウムを添加する方法の場合は、これらの薬剤を大量に添加する必要があるとともに、皮膚に対するこれら薬剤の刺激が強いといった不都合を生じることとなる。 However, in the case of a method of adding cetyltrimethylammonium halide or cetylpyridinium halide, it is necessary to add a large amount of these agents, and there is a disadvantage that the irritation of these agents to the skin is strong.
また、アミノ酸型界面活性剤を添加する方法の場合は、価格が非常に高く、製品化を検討する際にコスト面で不都合を生じる。 In addition, in the case of the method of adding an amino acid type surfactant, the price is very high, which causes inconvenience in terms of cost when considering commercialization.
本発明は係る実情に鑑みてなされたものであって、基布への吸着を防止して有効に殺菌消毒効果を発揮することができる殺菌消毒液と、この殺菌消毒液を基布に浸漬させた殺菌消毒剤とを提供することを目的としている。 The present invention has been made in view of such circumstances, and a sterilizing liquid capable of effectively exhibiting a sterilizing and disinfecting effect by preventing adsorption to the base cloth, and immersing the sterilizing and disinfecting liquid in the base cloth. The purpose is to provide an antiseptic and disinfectant.
上記課題を解決するための本発明の殺菌消毒液は、繊維材料から構成された基布に担持して使用される殺菌消毒液が、正電荷を帯びた殺菌消毒成分と、リシン、アルギニン、ヒスチジンおよびそれらの塩酸塩の中から選択される少なくとも1種以上のアミノ酸と、ノニオン系界面活性剤とを含有し、pH4〜9に調整されてなるものである。また、上記殺菌消毒液において、0.01〜5重量%の第四級アンモニウム塩および/またはビグアナイド化合物からなる殺菌消毒成分と、0.05〜10重量%のアミノ酸と、0.05〜10重量%のノニオン系界面活性剤とを含む水溶液からなるものである。さらに、ノニオン系界面活性剤がポリオキシエチレン硬化ヒマシ油またはポリオキシエチレンソルビタン脂肪酸エステルとなされたものである。 The sterilizing liquid of the present invention for solving the above-mentioned problems is a sterilizing liquid used by being supported on a base fabric made of a fiber material, a sterilizing component having a positive charge, lysine, arginine, histidine. And at least one amino acid selected from the hydrochlorides thereof and a nonionic surfactant, and is adjusted to pH 4-9. In the sterilizing liquid, the sterilizing and disinfecting component comprising 0.01 to 5% by weight of a quaternary ammonium salt and / or a biguanide compound, 0.05 to 10% by weight of amino acid, and 0.05 to 10% by weight. % Nonionic surfactant and an aqueous solution containing it. Further, the nonionic surfactant is polyoxyethylene hydrogenated castor oil or polyoxyethylene sorbitan fatty acid ester.
また、上記課題を解決するための本発明の殺菌消毒剤は、上記殺菌消毒液が、基布に含浸されてなるものである。 Moreover, the disinfection agent of this invention for solving the said subject is what the said disinfection liquid is impregnated to a base fabric.
殺菌消毒成分としては、正電荷を帯びたものであれば特に限定されるものではない。具体的には、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化セチルピリジニウム、セトリミドなどの第四級アンモニウム塩、グルコン酸クロルヘキシジン、塩酸クロルヘキシジン、クロルヘキシジンなどのビグアナイド系化合物の中から選択される少なくとも1種以上を用いることができる。使用濃度としては、通常の殺菌消毒に用いられている濃度であれば、特に限定されるものではなく、0.01〜5重量%、より好ましくは0.01〜1重量%の濃度で用いられる。0.01重量%未満の場合、十分な殺菌効果を達成することができない。また、5重量%を越える場合は、皮膚に対する刺激が強くなり、しかも殺菌効果に限界が生じる上、不経済になってしまう。 The sterilizing / disinfecting component is not particularly limited as long as it has a positive charge. Specifically, at least one selected from quaternary ammonium salts such as benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, cetrimide, biguanide compounds such as chlorhexidine gluconate, chlorhexidine hydrochloride, chlorhexidine and the like. Can be used. The concentration used is not particularly limited as long as it is a concentration used for normal sterilization, and is used at a concentration of 0.01 to 5% by weight, more preferably 0.01 to 1% by weight. . When it is less than 0.01% by weight, a sufficient bactericidal effect cannot be achieved. On the other hand, if it exceeds 5% by weight, irritation to the skin becomes strong, the bactericidal effect is limited, and it becomes uneconomical.
アミノ酸としては、pH9.0以下で正電荷を有する、リシン、アルギニン、ヒスチジンおよびそれらの塩酸塩の中から選択される少なくとも1種以上を用いることができる。使用濃度としては、アミノ酸が0.05〜10重量%、より好ましくは0.1〜3重量%の濃度で用いられる。使用の目安は、殺菌消毒成分1重量部に対してアミノ酸0.01〜1000(好ましくは0.01〜60)重量部とされる。アミノ酸が0.05重量%未満の場合、ノニオン系界面活性剤を大量に入れないといけなくなり、コストがかかってしまう。また、アミノ酸が10重量%を越える場合は、コスト高になってしまう。特に、アルギニン、ヒスチジン、リシンを使用した場合は、それらを中和するために大量の酸が必要となり、コスト高につながる。 As the amino acid, at least one selected from lysine, arginine, histidine, and hydrochlorides thereof having a positive charge at pH 9.0 or lower can be used. As the use concentration, the amino acid is used in a concentration of 0.05 to 10% by weight, more preferably 0.1 to 3% by weight. The standard of use is 0.01 to 1000 (preferably 0.01 to 60) parts by weight of amino acid per 1 part by weight of the sterilizing and disinfecting component. If the amino acid content is less than 0.05% by weight, a large amount of nonionic surfactant must be added, which increases costs. Further, when the amino acid exceeds 10% by weight, the cost becomes high. In particular, when arginine, histidine, or lysine is used, a large amount of acid is required to neutralize them, leading to high costs.
ノニオン系界面活性剤としては、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油などを用いることができる。使用濃度としては、ノニオン系界面活性剤が0.05〜10重量%、より好ましくは0.1〜5重量%の濃度で用いられる。使用の目安は、殺菌消毒成分1重量部に対してノニオン系界面活性剤0.01〜1000(好ましくは0.01〜100)重量部とされる。ノニオン系界面活性剤が0.05重量%未満の場合、アミノ酸を大量に配合しなければならず、コスト高になってしまう。また、ノニオン系界面活性剤が10重量%を越えると、効果が飽和してしまうので、それ以上加える意味が無く、コスト高になってしまう。 As the nonionic surfactant, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, and the like can be used. As a use concentration, a nonionic surfactant is used at a concentration of 0.05 to 10% by weight, more preferably 0.1 to 5% by weight. The standard of use is 0.01 to 1000 (preferably 0.01 to 100) parts by weight of a nonionic surfactant with respect to 1 part by weight of the sterilizing and disinfecting component. If the nonionic surfactant is less than 0.05% by weight, a large amount of amino acid must be blended, resulting in an increase in cost. On the other hand, if the nonionic surfactant exceeds 10% by weight, the effect is saturated, so there is no point in adding more and the cost becomes high.
殺菌消毒液の溶媒としては、水、低級アルコール、またはこれらの混合溶媒を用いることができる。この溶媒に、上記した殺菌消毒成分と、上記したアミノ酸と、上記したノニオン系界面活性剤とを溶解して殺菌消毒液は構成される。 As a solvent for the sterilizing / disinfecting solution, water, lower alcohol, or a mixed solvent thereof can be used. The sterilizing / disinfecting solution is constituted by dissolving the above-described sterilizing / disinfecting component, the above-described amino acid, and the above-described nonionic surfactant in this solvent.
殺菌消毒液に配合可能な他の薬剤としては、リドカイン、ジブカイン、それらの塩などの局所麻酔剤、ナファゾリン、エフェドフリン、それらの塩などの血管収縮剤、ヒドロコルチゾン、プレドニゾロン、それらの塩などの副腎脂質ホルモン剤、ジフェンヒドラミン、クロルフェニラミン、それらの塩などの抗ヒスタミン剤、酸化亜鉛、パラフェノールスルホン酸亜鉛などの収斂剤、クロタミトン、カンフルなどの鎮痒剤、グリチルレチン酸及びその誘導体、インドメタシン、フェルビナクなどの鎮痛・消炎剤、ビホナゾール、トルナフテートなどの抗白癬菌剤、スルフイソキサゾール、スルファジアジンなどのサルファ剤、尿素、サリチル酸、レゾルシンなどの角質溶解剤、アラントインなどの組織修復剤、トコフェロール及びその塩、ビタミンB、ビタミンA、ビタミンDなどのビタミン剤、安息香酸及びそのナトリウム塩、パラオキシ安息香酸エステルなどの防腐剤、水、エタノール、イソプロパノール、プロピレングリコールのような多価アルコールおよびこれらの混合溶媒などの水性溶媒、オクチルドデカノールのようなアルコール類、ステアリン酸、オレイン酸のような脂肪酸類またはこれらの混合溶液などの油性溶媒が挙げられる。 Other drugs that can be included in the disinfectant solution include local anesthetics such as lidocaine, dibucaine and their salts, vasoconstrictors such as naphazoline, ephedofrine and their salts, adrenal lipids such as hydrocortisone, prednisolone and their salts Hormonal agents, diphenhydramine, chlorpheniramine, antihistamines such as their salts, astringents such as zinc oxide and zinc paraphenolsulfonate, antipruritic agents such as crotamiton and camphor, glycyrrhetinic acid and its derivatives, analgesics such as indomethacin and felbinac Anti-inflammatory agents such as anti-inflammatory agents, bifonazole and tolnaftate, sulfa drugs such as sulfisoxazole and sulfadiazine, keratolytic agents such as urea, salicylic acid and resorcin, tissue repair agents such as allantoin, tocopherol and its salts, bi Vitamins such as Min B, Vitamin A and Vitamin D, benzoic acid and its sodium salt, preservatives such as paraoxybenzoic acid ester, water, polyhydric alcohols such as ethanol, isopropanol and propylene glycol, and mixed solvents thereof Examples thereof include oily solvents such as aqueous solvents, alcohols such as octyldodecanol, fatty acids such as stearic acid and oleic acid, or a mixed solution thereof.
また、殺菌消毒液は、添加されるアミノ酸によりpH10以上になることが多いので、最終的にpH4〜9となるように調整される。このpHの調整は、pH4〜9、好ましくはpH5.0〜7.0に調整される。このpHが4未満の場合、皮膚刺激が強くなって好ましくない。また、pHが9を越えると、アミノ酸やノニオン系界面活性剤による効果が充分に発揮できなくなる。この調整に使用する酸としては、クエン酸、塩酸、グルコン酸、コハク酸、酢酸、酒石酸、乳酸、ホウ酸、マレイン酸、メタンスルホン酸、リンゴ酸、リン酸、硫酸などを使用することができる。なお、アミノ酸としてアミノ酸の塩酸塩を使用した場合や、その他の場合によっては、pH4〜9になる場合があるので、そのような場合はpH調整を行う必要はない。 Further, since the sterilizing / disinfecting solution often has a pH of 10 or more depending on the added amino acid, it is finally adjusted to have a pH of 4-9. This pH adjustment is adjusted to pH 4-9, preferably pH 5.0-7.0. When this pH is less than 4, the skin irritation becomes strong, which is not preferable. On the other hand, if the pH exceeds 9, the effects of amino acids and nonionic surfactants cannot be sufficiently exhibited. As the acid used for this adjustment, citric acid, hydrochloric acid, gluconic acid, succinic acid, acetic acid, tartaric acid, lactic acid, boric acid, maleic acid, methanesulfonic acid, malic acid, phosphoric acid, sulfuric acid and the like can be used. . In addition, since it may become pH 4-9 depending on the case where the hydrochloride of an amino acid is used as an amino acid or other cases, it is not necessary to adjust pH in such a case.
殺菌消毒液は、脱脂綿、ガーゼ、不織布などの基布に適量を担持させて使用される。殺菌消毒液を基布に担持させる方法としては、特に限定されるものではなく、例えば、殺菌消毒液を基布にスプレーするものであってもよいし、薬ビンから直接殺菌消毒液を基布に染み込ませるものであってもよい。また、基布が密封された袋体内に殺菌消毒液を注入するものであってもよいし、殺菌消毒液中に基布を浸漬させるものであってもよいし、流下する殺菌消毒液中に基布を通過させてフローコートするものであってもよい。 An appropriate amount of the sterilizing / disinfecting liquid is supported on a base fabric such as absorbent cotton, gauze, or non-woven fabric. The method for supporting the sterilizing / disinfecting liquid on the base cloth is not particularly limited. For example, the sterilizing / disinfecting liquid may be sprayed on the base cloth, or the sterilizing / disinfecting liquid may be directly applied from the medicine bottle. It may be soaked in. Further, the sterilizing liquid may be injected into the bag sealed with the base cloth, or the base cloth may be immersed in the sterilizing liquid. It may be flow-coated through a base fabric.
基布は、製造工程中に漂白工程が含まれており、この漂白工程で、セルロース分子中のグルコースの6位が酸化されてカルボキシル基が(COO- )となるために負の電荷を帯びている。 The base fabric includes a bleaching step in the manufacturing process, and in this bleaching step, the 6th position of glucose in the cellulose molecule is oxidized and the carboxyl group becomes (COO − ), and thus has a negative charge. Yes.
したがって、殺菌消毒液を基布に担持させて使用すると、殺菌消毒液中の殺菌消毒成分が基布のカルボキシル基(COO- )と結合して吸着してしまうことが懸念される。しかし、リシン、アルギニン、ヒスチジンおよびそれらの塩酸塩の中から選択される少なくとも1種以上のアミノ酸またはその塩酸塩はpH9.0以下で正電荷を有するので、このアミノ酸が、殺菌消毒成分よりも先に基布のカルボキシル基(COO- )と結合して殺菌消毒成分の吸着を防止することとなる。この場合、アミノ酸が、殺菌消毒成分よりも先に基布のカルボキシル基(COO- )と結合する作用は、殺菌消毒液中のノニオン系界面活性剤によって発揮される。 Accordingly, when the sterilizing / disinfecting liquid is supported on the base cloth, there is a concern that the sterilizing / disinfecting component in the sterilizing / disinfecting liquid may be bonded to and adsorbed with the carboxyl group (COO − ) of the base cloth. However, since at least one amino acid selected from lysine, arginine, histidine and a hydrochloride thereof or a hydrochloride thereof has a positive charge at a pH of 9.0 or less, the amino acid precedes the disinfecting component. It binds to the carboxyl group (COO − ) of the base fabric to prevent adsorption of the sterilizing and disinfecting components. In this case, the action of the amino acid binding to the carboxyl group (COO − ) of the base fabric prior to the sterilizing / disinfecting component is exhibited by the nonionic surfactant in the sterilizing / disinfecting solution.
この殺菌消毒液は、殺菌消毒液の有効成分を無駄にすることなく使用することができる。しかも、この有効成分が基布に吸着するのを防止している他の成分は、アミノ酸とノニオン系界面活性剤で、これら両成分は汎用されており安価である。したがって、この殺菌消毒液は、有効に殺菌消毒効果を発揮でき、しかも安全かつ安価に構成することができる。 This sterilizing / disinfecting solution can be used without wasting the active ingredients of the sterilizing / disinfecting solution. Moreover, other components that prevent this active ingredient from adsorbing to the base fabric are amino acids and nonionic surfactants, both of which are widely used and inexpensive. Therefore, this sterilizing / disinfecting solution can effectively exhibit the sterilizing / disinfecting effect, and can be configured safely and inexpensively.
この殺菌消毒液は、あらかじめ基布に浸漬させて殺菌消毒剤として構成しておいてもよい。基布としては、漂白処理を経たものが用いられる。もちろん、基布のカルボキシル基が負の電荷を帯びるのは、全て漂白処理に起因するものであるとは限らないので、漂白処理していない基布であっても、殺菌消毒液の吸着防止効果は得られる。具体的な基布としては、綿、レーヨン、パルプ・レーヨン不織布、脱脂綿、ガーゼなどが挙げられる。また、基布として水解性、非水解性のいずれであっても使用することができるが、パルプ・レーヨン不織布のような水解性のものを使用した場合は、殺菌消毒成分の吸着防止効果がより顕著になる。 This sterilizing / disinfecting solution may be preliminarily immersed in a base cloth and configured as a sterilizing / disinfecting agent. As the base fabric, a fabric subjected to bleaching treatment is used. Of course, the fact that the carboxyl group of the base fabric is negatively charged is not always due to the bleaching treatment, so even if the base fabric has not been bleached, the antibacterial disinfectant can prevent adsorption. Is obtained. Specific examples of the base fabric include cotton, rayon, pulp / rayon nonwoven fabric, absorbent cotton, and gauze. In addition, it can be used as a base fabric, either water-degradable or non-water-degradable. However, when a water-degradable material such as a pulp / rayon nonwoven fabric is used, the effect of preventing the adsorption of sterilizing and disinfecting components is further improved. Become prominent.
このように、あらかじめ基布に含浸させて構成した殺菌消毒剤の場合は、実際に使用するまでの時間、すなわち、殺菌消毒液が基布に含浸した状態になっている時間が長いので、殺菌消毒成分の吸着防止効果は、より顕著に発揮することができる。 In this way, in the case of a disinfectant preliminarily impregnated in a base cloth, the time until actual use, that is, the time in which the disinfectant is impregnated in the base cloth is long. The anti-adsorption effect of the disinfecting component can be exhibited more remarkably.
基布に浸漬させる殺菌消毒液の量としては、基布1重量部に対して1〜5重量部、好ましくは2〜4重量部となるように含浸させる。この殺菌消毒液の量が1重量部未満の場合は、殺菌消毒液の絶対量が少ないので、殺菌消毒成分の吸着防止効果が得られたとしても、充分な量の殺菌消毒成分を確保することができなくなってしまう。また、この殺菌消毒液の量が5重量部よりも多い場合は、基布に殺菌消毒液を担持させておくことができなくなり、殺菌消毒液が無駄になってしまう。 The amount of the sterilizing / disinfecting solution to be immersed in the base cloth is 1 to 5 parts by weight, preferably 2 to 4 parts by weight with respect to 1 part by weight of the base cloth. When the amount of the sterilizing liquid is less than 1 part by weight, the absolute amount of the sterilizing liquid is small, so even if an anti-adsorption effect of the sterilizing liquid is obtained, a sufficient amount of the sterilizing liquid must be secured. Will not be able to. When the amount of the sterilizing / disinfecting liquid is more than 5 parts by weight, the sterilizing / disinfecting liquid cannot be carried on the base cloth, and the sterilizing / disinfecting liquid is wasted.
なお、殺菌消毒成分によっては、最初の仕込み量の半分(例えば、殺菌消毒成分が下限値の0.01重量%である場合は、その半分である0.005重量%)も残っていれば、充分な効果が見込まれるものもあるので、吸着防止効果の目安としては、吸着率が50%以下となる範囲で、殺菌消毒成分、アミノ酸、ノニオン系界面活性剤のそれぞれの量とpHとが適宜調整される。もちろん、殺菌消毒成分、アミノ酸、ノニオン系界面活性剤のそれぞれの量とpHとを最適に調整することで、ほぼ吸着しないようにすることも可能である。これらは、各殺菌消毒剤に求められる有効成分量に応じて決定される。
以下に、殺菌消毒剤の具体例を示す。
Depending on the sterilizing and disinfecting component, if half of the initial charge amount (for example, if the disinfecting and disinfecting component is 0.01% by weight of the lower limit value, 0.005% by weight which is a half thereof) remains, Since there are those that are expected to have sufficient effects, the amount of antibacterial disinfecting component, amino acid, and nonionic surfactant should be adjusted appropriately as a guideline for the adsorption preventing effect within a range where the adsorption rate is 50% or less. Adjusted. Needless to say, it is possible to prevent adsorption by adjusting the respective amounts and pH of the sterilizing / disinfecting component, amino acid and nonionic surfactant optimally. These are determined according to the amount of active ingredients required for each disinfectant.
Below, the specific example of a disinfection disinfectant is shown.
1.痔疾薬
塩化ベンザルコニウム0.1重量%、リドカイン3.0重量%、dl−塩酸メチルエフェドリン0.5重量%、L−アルギニン0.4重量%およびポリオキシエチレン硬化ヒマシ油60 0.5重量%を含む水溶液を、パルプ・レーヨンよりなる不織布(20×10cm)に3ml湿潤させ、アルミラミネートフィルムに入れてヒートシールして製する。
1. Antiepileptic drug benzalkonium chloride 0.1 wt%, lidocaine 3.0 wt%, dl-methylephedrine hydrochloride 0.5 wt%, L-arginine 0.4 wt% and polyoxyethylene hydrogenated castor oil 60 0.5 wt% 3 ml of a non-woven fabric made of pulp / rayon (20 × 10 cm) is wetted in an aluminum laminate film and heat sealed.
2.水虫・たむし薬
ビホナゾール1.0重量%、クロタミトン5.0重量%、グリチルレチン酸0.5重量%、リドカイン2.0重量%、塩化ベンゼトニウム0.05重量%、L−アルギニン0.4重量%およびポリオキシエチレン硬化ヒマシ油60 0.5重量%を含む水溶液を、レーヨンよりなる不織布(20×10cm)に3ml湿潤させ、アルミラミネートフィルムに入れてヒートシールして製する。
2. Athlete's footworm bifonazole 1.0% by weight, crotamiton 5.0% by weight, glycyrrhetinic acid 0.5% by weight, lidocaine 2.0% by weight, benzethonium chloride 0.05% by weight, L-arginine 0.4% by weight and 3 ml of an aqueous solution containing 0.5% by weight of polyoxyethylene hydrogenated castor oil 60 is wetted with a non-woven fabric (20 × 10 cm) made of rayon, put into an aluminum laminate film, and heat sealed.
3.きず薬
塩化ベンザルコニウム0.1重量%、アラントイン0.2重量%、マレイン酸クロルフェニラミン0.2重量%、L−アルギニン0.4重量%およびポリオキシエチレン硬化ヒマシ油60 0.7重量%を含む水溶液を、ガーゼもしくはレーヨンよりなる不織布(20×10cm)に3ml湿潤させ、アルミラミネートフィルムに入れてヒートシールして製する。
3. Kazu medicine 0.1% by weight of benzalkonium chloride, 0.2% by weight of allantoin, 0.2% by weight of chlorpheniramine maleate, 0.4% by weight of L-arginine and 60% by weight of polyoxyethylene hydrogenated castor oil 60 3 ml of an aqueous solution containing% is wetted with a non-woven fabric (20 × 10 cm) made of gauze or rayon, placed in an aluminum laminate film, and heat sealed.
4.手指又は感染皮膚面の殺菌消毒剤
塩化ベンザルコニウム0.05重量%、L−アルギニン0.4重量%およびポリオキシエチレン硬化ヒマシ油60 0.5重量%を含む水溶液を、レーヨンよりなる不織布(20×10cm)に3ml湿潤させ、アルミラミネートフィルムに入れてヒートシールして製する。
4). Disinfectant for finger or infected skin surface An aqueous solution containing 0.05% by weight of benzalkonium chloride, 0.4% by weight of L-arginine and 0.5% by weight of polyoxyethylene hydrogenated castor oil 60 is a nonwoven fabric made of rayon ( 20 ml × 10 cm) is wetted and placed in an aluminum laminate film and heat sealed.
5.鎮痒剤
ジフェンヒドラミン1.0重量%、グリチルリチン酸ジカリウム1.0重量%、塩化ベンザルコニウム0.1重量%、リドカイン2.0重量%、酢酸トコフェロール0.5重量%、L−アルギニン0.4重量%およびポリオキシエチレン硬化ヒマシ油60 0.5重量%を含む水溶液を、パルプ・レーヨンよりなる不織布(20×10cm)に3ml湿潤させ、アルミラミネートフィルムに入れてヒートシールして製する。
5). Antipruritic agent Diphenhydramine 1.0 wt%, Dipotassium glycyrrhizinate 1.0 wt%, Benzalkonium chloride 0.1 wt%, Lidocaine 2.0 wt%, Tocopherol acetate 0.5 wt%, L-arginine 0.4 wt% % And polyoxyethylene hydrogenated castor oil 60 0.5% by weight of an aqueous solution made of pulp / rayon (20 × 10 cm) is wetted by 3 ml, placed in an aluminum laminate film and heat sealed.
6.清浄綿
塩化ベンザルコニウム0.1重量%、L−アルギニン0.4重量%およびポリオキシエチレン硬化ヒマシ油60 0.5重量%を含む水溶液を、脱脂綿3gに9ml湿潤させ、アルミラミネートフィルムに入れてヒートシールして製する。
6). Clean cotton: 9 ml of an aqueous solution containing 0.1% by weight of benzalkonium chloride, 0.4% by weight of L-arginine and 0.5% by weight of polyoxyethylene hydrogenated castor oil 60 is moistened with 3 g of absorbent cotton and placed in an aluminum laminate film. Heat seal and make.
7.器具の殺菌消毒剤
塩化ベンザルコニウム0.1重量%、L−アルギニン0.4重量%およびポリオキシエチレン硬化ヒマシ油60 0.5重量%を含むエタノール水溶液を、レーヨンよりなる不織布(20×10cm)に3ml湿潤させ、アルミラミネートフィルムに入れてヒートシールして製する。
7). Disinfectant of instrument An aqueous ethanol solution containing 0.1% by weight of benzalkonium chloride, 0.4% by weight of L-arginine and 0.5% by weight of polyoxyethylene hydrogenated castor oil 60 is a nonwoven fabric made of rayon (20 × 10 cm). 3 ml), put in an aluminum laminate film and heat-seal.
以上述べたように、本発明によると、殺菌消毒成分の基布への吸着を防止して有効に殺菌消毒効果を発揮することができる。 As described above, according to the present invention, it is possible to effectively exhibit the sterilizing and disinfecting effect by preventing the sterilizing and disinfecting component from being adsorbed on the base fabric.
また、この殺菌消毒成分の基布への吸着防止は、殺菌消毒液に、リシン、アルギニン、ヒスチジンおよびそれらの塩酸塩の中から選択される少なくとも1種以上のアミノ酸と、ノニオン系界面活性剤とを含有し、pH4〜9に調整することによって安全かつ安価に達成することができる。 In addition, the antibacterial disinfecting component can be prevented from adsorbing on the base cloth by adding at least one amino acid selected from lysine, arginine, histidine and their hydrochlorides to the disinfecting disinfecting solution, and a nonionic surfactant. Can be achieved safely and inexpensively by adjusting to pH 4-9.
以下、本発明の実施の形態を説明する。
−実施例1〜22,比較例1〜5−
表1に示すように、各種の殺菌消毒成分、アミノ酸、ノニオン系界面活性剤を、表1に示す配合量で配合し、クエン酸でpH調整した水溶液とした。これらの水溶液を、各基布に基布重量の3 倍量となるように含浸させて、各試料を用意した。
Embodiments of the present invention will be described below.
-Examples 1-22, Comparative Examples 1-5
As shown in Table 1, various sterilizing / disinfecting components, amino acids, and nonionic surfactants were blended in the blending amounts shown in Table 1 to obtain an aqueous solution adjusted in pH with citric acid. Each sample was prepared by impregnating each aqueous solution with these aqueous solutions so as to be 3 times the weight of the base fabric.
各試料を25℃−65%RHで1日間放置後、絞り液中の殺菌消毒成分の濃度を測定した。 Each sample was allowed to stand at 25 ° C.-65% RH for 1 day, and then the concentration of the sterilizing / disinfecting component in the juice was measured.
それぞれの基布について調整した試料で3回試験を行い、測定された殺菌消毒成分の濃度の平均値から基布への殺菌消毒成分の吸着率を求め、吸着率が50%以下を良否判断の基準として、殺菌消毒成分の基布への吸着防止効果を確認した。 The test was performed three times with the samples prepared for each base fabric, and the adsorption rate of the sterilizing / disinfecting component to the base fabric was determined from the measured average concentration of the sterilizing / disinfecting component. As a standard, the effect of preventing the disinfecting and disinfecting components from adsorbing to the base fabric was confirmed.
また、比較対象として、殺菌消毒成分である塩化ベンザルコニウム0.1重量%を含む水溶液を調整し、この水溶液を各基布に含浸させたものについても同様の測定を行った。
結果を表1に示す。
For comparison, an aqueous solution containing 0.1% by weight of benzalkonium chloride, which is a sterilizing and disinfecting component, was prepared, and the same measurement was performed on each base fabric impregnated with this aqueous solution.
The results are shown in Table 1.
表1の結果より、アミノ酸、ノニオン系界面活性剤を配合して所定pHに調整した水溶液では、全ての実施例において、殺菌消毒成分が各種の基布に吸着するのを防止できることを確認できた。 From the results in Table 1, it was confirmed that in all the examples, the aqueous solution adjusted to a predetermined pH by adding an amino acid and a nonionic surfactant can prevent the disinfecting component from being adsorbed on various base fabrics. .
−実施例23〜38,比較例6〜9−
表2に示すように、各種の殺菌消毒成分、アミノ酸、ノニオン系界面活性剤を、表2に示す配合量で配合し、クエン酸でpH調整した水溶液とした。これらの水溶液を、各基布に基布重量の3 倍量となるように含浸させて、各試料を用意した。
-Examples 23-38, Comparative Examples 6-9-
As shown in Table 2, various sterilizing / disinfecting components, amino acids, and nonionic surfactants were blended in the blending amounts shown in Table 2, and the aqueous solution was adjusted to pH with citric acid. Each sample was prepared by impregnating each aqueous solution with these aqueous solutions so as to be 3 times the weight of the base fabric.
各試料を25℃−65%RHで1日間放置後、絞り液中の殺菌消毒成分の濃度を測定した。 Each sample was allowed to stand at 25 ° C.-65% RH for 1 day, and then the concentration of the sterilizing / disinfecting component in the juice was measured.
それぞれの基布について調整した試料で3回試験を行い、測定された殺菌消毒成分の濃度の平均値から基布への殺菌消毒成分の吸着率を求め、吸着率が50%以下を良否判断の基準として、殺菌消毒成分の基布への吸着防止効果を確認した。 The test was performed three times with the samples prepared for each base fabric, and the adsorption rate of the sterilizing / disinfecting component to the base fabric was determined from the measured average concentration of the sterilizing / disinfecting component. As a standard, the effect of preventing the disinfecting and disinfecting components from adsorbing to the base fabric was confirmed.
また、比較対象として、表2に示す各配合量の水溶液を調整し、これらの水溶液を基布に含浸させたものについても同様の測定を行った。
結果を表2に示す。
Moreover, the same measurement was performed also about what adjusted the aqueous solution of each compounding quantity shown in Table 2 as a comparison object, and impregnated these aqueous solutions to the base fabric.
The results are shown in Table 2.
表2の結果より、殺菌消毒成分、アミノ酸、ノニオン系界面活性剤の各配合量が極端に多い場合または極端に少ない場合においても、殺菌消毒成分が基布に吸着するのを防止できることが確認できた。 From the results in Table 2, it can be confirmed that the disinfecting component can be prevented from adsorbing to the base fabric even when the amount of each of the disinfecting component, amino acid, and nonionic surfactant is extremely large or extremely small. It was.
−実施例39,40,比較例10−
表3に示すように、殺菌消毒成分として塩化ベンザルコニウム0.1重量%、アミノ酸としてL−アルギニン0.4重量%、ノニオン系界面活性剤としてポリオキシエチレン硬化ヒマシ油0.5重量%を配合し、クエン酸でpH9とpH8とにそれぞれ調整した水溶液とした。これらの水溶液を、各基布に基布重量の3 倍量となるように含浸させて、各試料を用意した。
-Examples 39 and 40, Comparative Example 10-
As shown in Table 3, 0.1% by weight of benzalkonium chloride as a sterilizing and disinfecting component, 0.4% by weight of L-arginine as an amino acid, and 0.5% by weight of polyoxyethylene hydrogenated castor oil as a nonionic surfactant. The aqueous solutions were mixed and adjusted to pH 9 and pH 8 with citric acid, respectively. Each sample was prepared by impregnating each aqueous solution with these aqueous solutions so as to be 3 times the weight of the base fabric.
各試料を25℃−65%RHで1日間放置後、絞り液中の殺菌消毒成分の濃度を測定した。 Each sample was allowed to stand at 25 ° C.-65% RH for 1 day, and then the concentration of the sterilizing / disinfecting component in the juice was measured.
それぞれの基布について調整した試料で3回試験を行い、測定された殺菌消毒成分の濃度の平均値から基布への殺菌消毒成分の吸着率を求め、吸着率が50%以下を良否判断の基準として、殺菌消毒成分の基布への吸着防止効果を確認した。 The test was performed three times with the samples prepared for each base fabric, and the adsorption rate of the sterilizing / disinfecting component to the base fabric was determined from the measured average concentration of the sterilizing / disinfecting component. As a standard, the effect of preventing the disinfecting and disinfecting components from adsorbing to the base fabric was confirmed.
また、比較対象として、クエン酸でpH調整しない水溶液を用い、この水溶液を基布に含浸させたものについても同様の測定を行った。
結果を表3に示す。
For comparison, an aqueous solution that was not adjusted in pH with citric acid was used, and the same measurement was carried out on a base fabric impregnated with this aqueous solution.
The results are shown in Table 3.
表3の結果より、殺菌消毒成分の基布への吸着防止効果が、pH調整によって大きく影響され、pH9以下では、この吸着防止効果を充分に発揮できることが確認できた。 From the results shown in Table 3, it was confirmed that the adsorption preventing effect of the sterilizing / disinfecting component on the base fabric was greatly influenced by the pH adjustment, and that the adsorption preventing effect could be sufficiently exhibited at pH 9 or lower.
本発明は、殺菌消毒液を基布に浸漬させた各種の製剤としてとして使用される。 The present invention is used as various preparations in which a disinfectant solution is immersed in a base cloth.
Claims (6)
The disinfectant according to claim 5, wherein the base fabric is a pulp / rayon nonwoven fabric.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008203929A JP5469829B2 (en) | 2008-08-07 | 2008-08-07 | Disinfectant and disinfectant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008203929A JP5469829B2 (en) | 2008-08-07 | 2008-08-07 | Disinfectant and disinfectant |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010037295A true JP2010037295A (en) | 2010-02-18 |
JP5469829B2 JP5469829B2 (en) | 2014-04-16 |
Family
ID=42010195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008203929A Active JP5469829B2 (en) | 2008-08-07 | 2008-08-07 | Disinfectant and disinfectant |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5469829B2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012197250A (en) * | 2011-03-22 | 2012-10-18 | Lion Corp | Sheet cosmetic product |
JP2012250959A (en) * | 2011-06-06 | 2012-12-20 | Air Water Mach Inc | Antibacterial deodorant |
JP2015048443A (en) * | 2013-09-03 | 2015-03-16 | 国立大学法人群馬大学 | Support for disinfectant impregnation |
JP2016175879A (en) * | 2015-03-20 | 2016-10-06 | 旭化成株式会社 | Wet wiper and method for producing the same |
JP6302121B1 (en) * | 2016-11-30 | 2018-03-28 | 株式会社Adeka | Cleaning sheet |
JP2018511607A (en) * | 2015-04-02 | 2018-04-26 | バイオトロル・ピーエルシー | Antimicrobial composition |
JP2019532024A (en) * | 2016-08-11 | 2019-11-07 | エコラボ ユーエスエー インコーポレイティド | Interactions between antimicrobial quaternary compounds and anionic surfactants |
JP2020011953A (en) * | 2018-07-05 | 2020-01-23 | ロート製薬株式会社 | Water-disintegrable sheet agent for external use and method for improving water-disintegrable sheet agent for external use |
CN114502052A (en) * | 2019-10-25 | 2022-05-13 | 花王株式会社 | Wiping material |
US11406103B2 (en) | 2016-03-01 | 2022-08-09 | Ecolab Usa Inc. | Sanitizing rinse based on quat-anionic surfactant synergy |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06102604B2 (en) * | 1985-08-27 | 1994-12-14 | 武田薬品工業株式会社 | Disinfectant |
JPH08151325A (en) * | 1994-11-28 | 1996-06-11 | Sunstar Inc | Antimicrobial preparation |
JPH08151326A (en) * | 1994-11-28 | 1996-06-11 | Sunstar Inc | Antimicrobial preparation |
-
2008
- 2008-08-07 JP JP2008203929A patent/JP5469829B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06102604B2 (en) * | 1985-08-27 | 1994-12-14 | 武田薬品工業株式会社 | Disinfectant |
JPH08151325A (en) * | 1994-11-28 | 1996-06-11 | Sunstar Inc | Antimicrobial preparation |
JPH08151326A (en) * | 1994-11-28 | 1996-06-11 | Sunstar Inc | Antimicrobial preparation |
Non-Patent Citations (2)
Title |
---|
JPN4007007646; 歯薬療法 第5巻,第2号,1986年, p.105〜108 * |
JPN7013001404; 齋藤好廣、日本油化学会誌、2000年、49(10)、1071-1080頁 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012197250A (en) * | 2011-03-22 | 2012-10-18 | Lion Corp | Sheet cosmetic product |
JP2012250959A (en) * | 2011-06-06 | 2012-12-20 | Air Water Mach Inc | Antibacterial deodorant |
JP2015048443A (en) * | 2013-09-03 | 2015-03-16 | 国立大学法人群馬大学 | Support for disinfectant impregnation |
JP2016175879A (en) * | 2015-03-20 | 2016-10-06 | 旭化成株式会社 | Wet wiper and method for producing the same |
JP2018511607A (en) * | 2015-04-02 | 2018-04-26 | バイオトロル・ピーエルシー | Antimicrobial composition |
US11406103B2 (en) | 2016-03-01 | 2022-08-09 | Ecolab Usa Inc. | Sanitizing rinse based on quat-anionic surfactant synergy |
US11044907B2 (en) | 2016-08-11 | 2021-06-29 | Ecolab Usa Inc. | Interaction between antimicrobial quaternary compounds and anionic surfactants |
JP2019532024A (en) * | 2016-08-11 | 2019-11-07 | エコラボ ユーエスエー インコーポレイティド | Interactions between antimicrobial quaternary compounds and anionic surfactants |
US11839209B2 (en) | 2016-08-11 | 2023-12-12 | Ecolab Usa Inc. | Interaction between antimicrobial quaternary compounds and anionic surfactants |
JP2018090564A (en) * | 2016-11-30 | 2018-06-14 | 株式会社Adeka | Cleaning sheet |
JP6302121B1 (en) * | 2016-11-30 | 2018-03-28 | 株式会社Adeka | Cleaning sheet |
JP2020011953A (en) * | 2018-07-05 | 2020-01-23 | ロート製薬株式会社 | Water-disintegrable sheet agent for external use and method for improving water-disintegrable sheet agent for external use |
CN114502052A (en) * | 2019-10-25 | 2022-05-13 | 花王株式会社 | Wiping material |
CN114502052B (en) * | 2019-10-25 | 2023-12-26 | 花王株式会社 | Wiping material |
Also Published As
Publication number | Publication date |
---|---|
JP5469829B2 (en) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5469829B2 (en) | Disinfectant and disinfectant | |
KR100437566B1 (en) | Disinfectant composition comprising alcohol, chlorhexidine and an organic acid | |
JP5689817B2 (en) | Chlorhexidine acetate disinfectant cleaner | |
KR101555341B1 (en) | Antibiotic wet tissue, and manufacturing method thereof | |
US7829099B2 (en) | Self-adhesive polymer matrix containing sea algae extract and glycerin | |
EP3205211B1 (en) | Alcohol-based antiviral composition | |
JP2010527933A5 (en) | ||
JP2010527933A (en) | Phospholipid compositions for contact lens care and preserving pharmaceutical compositions | |
JP2018502226A (en) | Liquid impregnated nonwoven fabric containing cellulose fibers containing zinc oxide | |
CN105079858B (en) | Liquid dressing and its preparation method are repaired in a kind of wound sterilization | |
EP3413869B1 (en) | Antimicrobial and cleansing composition consisting of a polymeric biguanide and edta | |
ES2382017T3 (en) | Virucidal disinfectant | |
JP2018188368A (en) | Wet Wiper | |
JP2000191521A (en) | Sterilizer | |
ES2616495T3 (en) | Composition in gel form for virucidal disinfection of mammalian skin | |
WO2004105492A1 (en) | Aqueous compositions for disinfection and/or sterilization | |
JPH0741062B2 (en) | Composition for outer skin | |
JP2003319887A (en) | Sterilizing wet tissue and method for manufacturing the same | |
JP3062097B2 (en) | Sterilizable wet wiper and method for producing the same | |
CN107646862B (en) | Olanexidine aqueous solution based on ascorbic acid and preparation method and application thereof | |
JP3253769B2 (en) | Chlorhexidine-containing disinfectant composition | |
RU2805604C2 (en) | Disinfectant composition | |
US20220249407A1 (en) | Aqueous antiseptic composition having improved antibacterial persistence comprising chlorhexidine or derivative thereof and fabric type antiseptic comprising same | |
US20230413812A1 (en) | Sanitizing compositions containing ionic liquid | |
DK2623102T3 (en) | PREPARATION FOR TRANSDERMAL ABSORPTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110609 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130423 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130531 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130820 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131108 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20131118 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140114 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140203 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5469829 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |